Log in to save to my catalogue

Circulating tumor cell-derived preclinical models: current status and future perspectives

Circulating tumor cell-derived preclinical models: current status and future perspectives

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_76914d3e92714ee7a0aaef1af6d4853f

Circulating tumor cell-derived preclinical models: current status and future perspectives

About this item

Full title

Circulating tumor cell-derived preclinical models: current status and future perspectives

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2023-08, Vol.14 (8), p.530-12, Article 530

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Despite the advancements made in the diagnosis and treatment of cancer, the stages associated with metastasis remain largely incurable and represent the primary cause of cancer-related deaths. The dissemination of cancer is facilitated by circulating tumor cells (CTCs), which originate from the primary tumor or metastatic sites and enter the bloods...

Alternative Titles

Full title

Circulating tumor cell-derived preclinical models: current status and future perspectives

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_76914d3e92714ee7a0aaef1af6d4853f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_76914d3e92714ee7a0aaef1af6d4853f

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-023-06059-6

How to access this item